Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5571448 | Primary Care Diabetes | 2017 | 7 Pages |
Abstract
A clearly defined and relatively simple personalised approach leads to a higher proportion of T2DM patients considered as cardiometabolic well-controlled. This approach may especially be beneficial for patients aged â¥70 years on more than metformin monotherapy (HbA1c) and for patients aged â¥80 years (SBP). Precisely these patients are suggested not to benefit from stricter HbA1c or SBP targets, whereas they may experience more adverse effects (e.g. hypoglycaemia, postural hypotension) when a stricter target value is pursued.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Anne Meike Boels, Huberta E. Hart, Guy E. Rutten, Rimke C. Vos,